Prezista 400Mg 400mg Tablet
PDF Leaflet Revision Date: 2 June 2017
Clinical Summary
Quick overview from the medicine insert
Indication
Treatment of HIV infection in antiretroviral treatment experienced adult patients.
Dosage (summary)
800 mg darunavir with 100 mg ritonavir once daily with food.
Special Populations
- Elderly
- Hepatic impairment
- Renal impairment
Pregnancy & Breastfeeding
Safety not established; avoid breastfeeding.
Key Drug Interactions
- CYP3A inhibitors
- Rifampicin
- St. John's Wort
Contraindications
- Hypersensitivity to darunavir
- Severe hepatic impairment
- Concomitant use with certain CYP3A substrates
Common side effects
- Rash
- Diarrhea
- Headache
- Hyperglycemia
Counselling Points
- Take with food
- Monitor for skin reactions
- Use alternative contraception methods
Serious warnings
- Severe skin reactions
- Hepatotoxicity
- Immune reconstitution inflammatory syndrome
Important Disclaimer
The Prezista 400Mg 400mg Tablet professional information leaflet below is the property of Aspen Pharmacare and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
